Zum Inhalt springen
Radio Logo
PodcastsBildungListen to Gynecologic Oncology

Listen to Gynecologic Oncology

Gynecologic Oncology
Neueste Episode

74 Episoden

  • Listen to Gynecologic Oncology

    MEK-Ing Progress: Two Years of Avutometinib and Defactinib in Low-Grade Serous Ovarian Cancer

    03.11.2026 | 38 Min.
    Editor's Choice:  Long-term efficacy and safety of avutometinib + defactinib in recurrent low-grade serous ovarian cancer: Results of a 2-year follow-up of ENGOT-OV60/GOG-3052/RAMP 201

    Editorial: MEK-Ing progress in low-grade serous ovarian cancer

    Hosted by: 
    Ursula Matulonis, MD, 
    Dana-Farber Cancer Institute, Boston, United States of America
    Featuring: 
    Rachel N. Grisham MD, 
    Memorial Sloan Kettering Cancer Center, New York, United States of America
    David M. Gershenson, MD, 
    The University of Texas MD Anderson Cancer Center, Houston, United States of America

    Check out more content on the journal's homepage  at https://www.gynecologiconcology-online.net
  • Listen to Gynecologic Oncology

    Do We Have the Courage? Pregnancy, Policy, and the Price Surgeons Pay

    28.09.2026 | 41 Min.
    Editor's Choice:  Pregnancies in gynecologic oncologists: An assessment of pregnancy policies and complications within a surgical subspecialty

    Editorial: Pregnancy complications in gynecologic oncologists – A call to action to do better

    Hosted by: 
    Paola Gehrig, MD
    University of Virginia , Charlottesville,  United States of America
    Featuring: 
    Kelsey Goon, MD
    University of Chicago, United States of America
    Kathryn A. Mills, MD
    University of Chicago, United States of America
    Christine S. Walsh, MD
    University of Colorado School of Medicine, United States of America
    Brooke Sanders, MD
    Washington University School of Medicine, United States of America
    Check out more content on the journal's homepage  at https://www.gynecologiconcology-online.net
  • Listen to Gynecologic Oncology

    FIGO 2023 Upstaging: Overtreatment or Overdue Precision?

    01.09.2026 | 31 Min.
    Editor's Choice:  FIGO 2023 staging may result in overtreatment of early-stage endometrial cancer

    Editorial: A path to precision in endometrial cancer management: Moving past FIGO 2023

    Hosted by: 
    David Gaffney, MD, PhD
    The University of Utah, Salt Lake City, Utah, United States of America
    Featuring: 
    Allison Roy, MD
    SUNY Upstate Medical University, Syracuse, NY, United States of America
    Jessica N. McAlpine
    University of British Columbia,  Vancouver, BC, Canada
    David Mutch
    Washington University School of Medicine, St Louis, MO, United States of America
    Check out more content on the journal's homepage  at https://www.gynecologiconcology-online.net
  • Listen to Gynecologic Oncology

    ERAS 2026: Key Updates Every Gynecologic Oncologist Should Know

    31.07.2026 | 26 Min.
    Editor's Choice:  Enhanced recovery after surgery (ERAS®) society guidelines for gynecologic oncology: 2026 update

    Editorial: The evolving landscape of personalized perioperative care: A commentary on the 2026 ERAS® Gynecologic oncology guidelines

    Hosted by: 
    Sean C. Dowdy, MD; Division of Gynecologic Oncology, Mayo Clinic College of Medicine, Rochester, MN, USA
    Featuring: 
    Gregg Nelson, MD, PhD; Department of Obstetrics & Gynecology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
    Richard D. Urman, MD; Department of Anesthesiology, The Ohio State University Wexner Medical Center and College of Medicine, Columbus, OH, USA
    Olle Ljungqvist, MD, PhD; Department of Molecular Medicine & Surgery, Karolinska Institutet, Stockholm, Sweden
    Check out more content on the journal's homepage  at https://www.gynecologiconcology-online.net
  • Listen to Gynecologic Oncology

    Beyond the Binary: Unpacking Molecular Diversity in PMMR Endometrial Cancer

    29.07.2026 | 25 Min.
    Editor's Choice:  Biomarker heterogeneity and efficacy of durvalumab plus carboplatin/paclitaxel followed by durvalumab with or without olaparib in patients with mismatch repair proficient endometrial cancer: exploratory analyses of the DUO-E/GOG-3041/ENGOT-EN10 trial

    Editorial: Hitting the mark—or missing it? The promise and peril of biomarkers in endometrial cancer

    Hosted by: 
    Amanda Nickles Fader, MD; Johns Hopkins Medicine Baltimore, MD, USA
    Featuring: 
    Kathleen Moore, MD; Gynecologic Cancer Clinic, Stephenson Cancer Center at the University of Oklahoma Medical Center, Oklahoma City, OK, USA
    Ramez N Eskander, MD;  Department of Obstetrics, Gynecology and Reproductive Sciences, Division of Gynecologic Oncology, UC San Diego, USA

    Check out more content on the journal's homepage  at https://www.gynecologiconcology-online.net
Weitere Bildung Podcasts
Über Listen to Gynecologic Oncology
Stay informed with the latest research and emerging topics in gynecologic oncology through our monthly podcast series. Each episode features a dynamic conversation hosted by one of our Journal’s esteemed editors, who speaks with the authors of the Editor’s Choice article and the accompanying commentarial.
Podcast-Website

Höre Listen to Gynecologic Oncology, Easy German: Learn German with native speakers | Deutsch lernen mit Muttersprachlern und viele andere Podcasts aus aller Welt mit der radio.at-App

Hol dir die kostenlose radio.at App

  • Sender und Podcasts favorisieren
  • Streamen via Wifi oder Bluetooth
  • Unterstützt Carplay & Android Auto
  • viele weitere App Funktionen
Listen to Gynecologic Oncology: Zugehörige Podcasts
Rechtliches
Social
v8.27.0 | © 2007-2026 radio.de GmbH
Built: 11/16/2026 - 1:18:40 PM